Aptamer‐functionalized quantum dots as theranostic nanotools against cancer and bacterial infections: a comprehensive overview of recent trends
F Davodabadi, S Mirinejad… - Biotechnology …, 2023 - Wiley Online Library
Aptamers (Apts) are synthetic nucleic acid ligands that can be engineered to target various
molecules, including amino acids, proteins, and pharmaceuticals. Through a series of …
molecules, including amino acids, proteins, and pharmaceuticals. Through a series of …
Prostate cancer: measuring PSA
Population screening with prostate‐specific antigen (PSA) for detection of prostate cancer is
a topic associated with ongoing dissent and confusion within the oncology and wider …
a topic associated with ongoing dissent and confusion within the oncology and wider …
A new paradigm in public health assessment: water fingerprinting for protein markers of public health using mass spectrometry
J Rice, B Kasprzyk-Hordern - TrAC Trends in Analytical Chemistry, 2019 - Elsevier
Public health monitoring cannot currently provide real time and comprehensive information
about the health of a community as it depends on individual data collection (eg surveys) and …
about the health of a community as it depends on individual data collection (eg surveys) and …
Hybrid Machine Learning Algorithms to Evaluate Prostate Cancer
D Morakis, A Adamopoulos - Algorithms, 2024 - mdpi.com
The adequacy and efficacy of simple and hybrid machine learning and Computational
Intelligence algorithms were evaluated for the classification of potential prostate cancer …
Intelligence algorithms were evaluated for the classification of potential prostate cancer …
Intermittent hormone therapy models analysis and Bayesian model comparison for prostate cancer
S Pasetto, H Enderling, RA Gatenby… - Bulletin of Mathematical …, 2022 - Springer
The prostate is an exocrine gland of the male reproductive system dependent on androgens
(testosterone and dihydrotestosterone) for development and maintenance. First-line therapy …
(testosterone and dihydrotestosterone) for development and maintenance. First-line therapy …
Novel combinatorial approaches to tackle the immunosuppressive microenvironment of prostate cancer
EG Shackleton, HY Ali, M Khan, GA Pockley… - Cancers, 2021 - mdpi.com
Simple Summary The mainstay of treatment for advanced prostate cancer (PCa) is androgen
deprivation therapy (ADT), and although patients initially respond, almost all will eventually …
deprivation therapy (ADT), and although patients initially respond, almost all will eventually …
The effect of bicycling on PSA levels: a systematic review and meta-analysis
D Jiandani, A Randhawa, RE Brown… - Prostate cancer and …, 2015 - nature.com
Background: Recent literature has suggested that bicycling may be associated with
increases in serum PSA levels, a diagnostic and prognostic marker for prostate cancer. To …
increases in serum PSA levels, a diagnostic and prognostic marker for prostate cancer. To …
Shrinkage of Prostate and Improved Quality of Life: Management of BPH Patients with Croton membranaceus Ethanolic Root Extract
GA Asare, D Afriyie, RA Ngala… - Evidence‐Based …, 2015 - Wiley Online Library
Benign prostatic hyperplasia (BPH) is an enlargement of the prostate. The study aimed at
validating the use of freeze‐dried Croton membranaceus ethanolic root extract for BPH …
validating the use of freeze‐dried Croton membranaceus ethanolic root extract for BPH …
[HTML][HTML] GV1001 interacts with androgen receptor to inhibit prostate cell proliferation in benign prostatic hyperplasia by regulating expression of molecules related to …
Y Kim, D Lee, H Jo, C Go, J Yang, D Kang… - Aging (albany …, 2021 - ncbi.nlm.nih.gov
Prostate cell proliferation, driven by testosterone, is a major characteristic of benign prostatic
hyperplasia (BPH). GV1001, a human telomerase reverse transcriptase catalytic subunit, is …
hyperplasia (BPH). GV1001, a human telomerase reverse transcriptase catalytic subunit, is …
[PDF][PDF] Significance of detection of free/total PSA ratio and other biochemical parameters in patients with BPH, carcinoma prostate and its clinicopathologic correlation
S Joshi, MA Tilak, S Jadhav - International Journal, 2021 - ojs.tdmu.edu.ua
Background. Benign prostatic hyperplasia (BPH) can raise prostate-specific antigen (PSA)
levels two to three times higher than the normal level. An increased PSA level does not …
levels two to three times higher than the normal level. An increased PSA level does not …